Bi-or multifunctional opioid peptide drugs

PW Schiller - Life sciences, 2010 - Elsevier
Strategies for the design of bi-or multifunctional drugs are reviewed. A distinction is made
between bifunctional drugs interacting in a monovalent fashion with two targets and ligands …

Opioid receptor targeting ligands for pain management: a review and update

MP Davis - Expert Opinion on Drug Discovery, 2010 - Taylor & Francis
Importance of the field: Discovery and synthesis of analgesic ligands can potentially improve
analgesia, reduce side effects, minimize psychologic dependence and delay analgesic …

Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines

T Yamamoto, P Nair, NE Jacobsen… - Journal of medicinal …, 2010 - ACS Publications
Neuropathic pain states and tolerance to opioids can result from system changes in the
CNS, such as up-regulation of the NK1 receptor and substance P, lead to antiopioid effects …

Compounds and methods for the detection of trpv-6 cancers and drug delivery

JM Stewart - US Patent App. 12/824,935, 2010 - Google Patents
Compounds containing TRPV6-binding peptides and their use in the detection and
diagnosis of cancer are described. Also described are methods for detecting and staging …

Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery

JM Stewart - 2010 - Google Patents
TRPV6-binding peptides derived from soricidin, and compounds or compositions thereof,
and their use in the detection and diagnosis of cancer are described. Also described are …

[PDF][PDF] Part I. Design and Synthesis of Bicyclic Internal Beta-turn Mimetics and Their Incorporation Into Biologically Active Ligands; Part Ii. Synthesis of Cyclic Peptides …

BJ Min - 2010 - Citeseer
I would like to give my sincere appreciation to my advisor Regents professor Victor J Hruby
for his generous support in my projects. His scientific foresight, sagacity, and always positive …